New Bod announced Philip does realize that although he appoints the.Middle East expert , shareholders still vote on it . Frank Holler has been the chairman for over seven years and was introduced by his buddy Ray Matthews. Holler sits on the board of what is it 7 companies and is CEO of at least 4 of them ? No wonder he has no time for Sva. A man who has made tens of millions of dollars on ID Biomedical, Angiotech and Xenon only has 150,000 shares ? What's wrong with this picture? MoneyMouth a retail investors has more shares. He'll most retail investors have more shares. He gets free options , in fact most of the board will cash in their free options . The entire board is in alignment and passive . They do nothing except for allowing the bought deal to go through , paying Ray Matthews $10 k a month for nothing , wasting money on stupid IR etc.
No pharma deals, no public collaborations, just fluff. Philip nothing changes with this appointment , let the shareholders vote.
Ms Sally